University Office (Division)
Permanent URI for this communityhttps://hdl.handle.net/2164/320
Browse
Search Results
Item Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D) : a phase 2–3 randomised trial(2018-03) Adams, Richard; Brown, Ewan; Brown, Louise; Butler, Rachel; Falk, Stephen; Fisher, David; Kaplan, Richard; Quirke, Phil; Richman, Susan; Samuel, Leslie; Seligman, Jenny; Seymour, Matt; Shui, Kai Keen; Wasan, Harpreet; Wilson, Richard; Maughan, Tim; University of Aberdeen.Aberdeen Centre for Evaluation
